Implantation of a left ventricular assist device as a destination therapy in Duchenne muscular dystrophy patients with end stage cardiac failure: Management and lessons learned

Neuromuscular Disorders

Volumn 25, Issue 1, 2015, Pages 19-23

  Iodice, Francesca ^a   Testa, Giuseppina ^a   Averardi, Marco ^a   Brancaccio, Gianluca ^a   Amodeo, Antonio ^a   Cogo, Paola ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Duchenne muscular dystrophy; Left ventricular assist device

Indexed keywords

PROTHROMBIN COMPLEX; STEROID; TRANEXAMIC ACID;

ABSENCE OF COMPLICATIONS; ADOLESCENT; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; CASE REPORT; CHILD; CHYLOTHORAX; CLINICAL PROTOCOL; CONGESTIVE CARDIOMYOPATHY; COUGHING; DESTINATION THERAPY; DUCHENNE MUSCULAR DYSTROPHY; EXTUBATION; HEART FAILURE; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; LENGTH OF STAY; MALE; MEDICAL DEVICE COMPLICATION; NASAL TEMPERATURE PROBE; NASOGASTRIC TUBE; NEAR INFRARED SPECTROSCOPY; NONINVASIVE VENTILATION; OPERATIVE BLOOD LOSS; PATIENT SELECTION; PEROPERATIVE CARE; PLEURA EFFUSION; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; RETROPHARYNGEAL BLEEDING; SCHOOL CHILD; THERAPY; THERMOMETER; TONGUE EDEMA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT PLANNING; CARDIOMYOPATHY, DILATED; COMPLICATION; HEART ASSIST DEVICE; HEART VENTRICLE; TREATMENT OUTCOME;

ADOLESCENT; CARDIOMYOPATHY, DILATED; CHILD; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; TREATMENT OUTCOME;

EID: 84919683239     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2014.08.008     Document Type: Article

References (30)

1. Manzur A.Y., Kinali M., Muntoni F. Update on the management of Duchenne muscular dystrophy. Arch Dis Child 2008, 93:986-990.
2. Wu R.S., Gupta S., Brown R.N. Clinical outcomes after cardiac transplantation in muscular dystrophy patients. J Heart Lung Transplant 2010, 29:432-438.
3. Leprince P., Combes A., Bonnet N., et al. Circulatory support for fulminant myocarditis: consideration for implantation, weaning and explantation. Eur J Cardiothorac Surg 2003, 24:399-403.
4. Kirklin J.K., Holman W.L. Mechanical circulatory support therapy as a bridge to transplant or recovery (new advances). Curr Opin Cardiol 2006, 21:120-126.
5. Park S.J., Tector A., Piccioni W., et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 2005, 129:9-17.
6. Westaby S., Banning A.P., Jarvik R., et al. First permanent implant of the Jarvik 2000 heart. Lancet 2000, 9(356):900-993.
7. Nussmeier N., Probert C., Hirsch D., et al. Anesthetic management for implantation of the Jarvik 2000 TM left ventricular assist system. Anesth Analg 2003, 97:964-971.
8. Frazier O.H., Myers T.J., Gregoric I.D., et al. Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system. Circulation 2002, 105(24):2855-2856.
9. Amodeo A., Adorisio R. Left ventricular assist device in Duchenne cardiomyopathy: can we change the natural history of cardiac disease?. Int J Cardiol 2012, 161:e43.
10. Ryan T., Jefferies J., Sawanhi H., et al. Implantation of the heart mate II and heart ware left ventricular assist devices in patients with duchenne muscular dystrophy: lessons learned from the first applications. ASAIO J 2014, 60:246-248.
11. Kirklin J.K., Naftel D.C., Pagani F.D., et al. Sixth INTERMACS annual report: a 10,000-patient database. J Heart Transplant 2014, 33:555-564.
12. Morris P. Duchenne muscular dystrophy: a challenge for the anaesthetist. Paediatr Anaesth 1997, 7:1-4.
13. Silversides C.K., Webb G.O., Harris V.A., et al. Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy. Am J Cardiol 2003, 91:769-772.
14. Muenster T., Mueller C., Forst J. Anesthetic management in patients with Duchenne muscular dystrophy undergoing orthopaedic surgery: a review of 232 cases. Eur J Anaesthesiol 2012, 29:489-494.
15. Sethna N.F., Rockoff M.A., Worthen H.M. Anesthesia-related complications in children with Duchenne muscular dystrophy. Anesthesiology 1988, 68(3):462-465.
16. Hayes J., Veyckemans F., Bissonnette B. Duchenne muscular dystrophy: an old anesthesia problem revisited. Paediatr Anaesth 2008, 18(2):100-106.
17. Schrer R. Intubation and ventilation during thoracic surgery in children. Anasthesiol Intensivmed Notfallmed Schmerzther 2006, 41(10):660-664.
18. Chumnanvej S., Wood M., MacGillivray T., et al. Perioperative echocardiographic examination for ventricular assist device implantation. Anesth Analg 2007, 105:583-601.
19. Mauermann W., Rehfeldt K., Park S. Transesophageal echocardiography in a patient in hemodynamic compromise after Jarvik 2000TM implantation: the suckdown effect. Anesth Analg 2008, 107:791-792.
20. Santamore W.P., Gray L.A. Left ventricular contributions to right ventricular systolic function during LVAD support. Ann Thorac Surg 1996, 61:350-356.
21. Argiriadou H., Anastasiadis K., Antonitsis P., et al. Use of cerebral oximetry for monitoring cardiac output during off-pump implantation of Jarvik 2000 left ventricular assist device. Artif Organs 2010, 34(3):267-271.
22. Saito T., Takenaka M., Miyai I., et al. Coagulation and fibrinolysis disorder in muscular dystrophy. Muscle Nerve 2001, 24(3):399-402.
23. Shapiro F., Zurakowski D., Sethna N.F. Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for duchenne muscular dystrophy scoliosis. Spine 2007, 32(20):2278-2283.
24. Grosu H.B., Lee Y.I., Lee J., et al. Diaphragm muscle thinning in patients who are mechanically ventilated. Chest 2012, 6:1455-1460.
25. Jaber S., Michelet P., Chanques G. Role of non-invasive ventilation (NIV) in the perioperative period. Best Pract Res Clin Anaesthesiol 2010, 2:253-265.
26. Iodice F., Testa G., Amodeo A. Inappropriate use of neurally adjusted ventilator assist. BMJ Case Rep 2012, 10.1136/bcr-10-2011-5029.
27. Theiss H.D., Grabmaier U., Kreissl N., et al. Preconditioning with levosimendan before implantation of left ventricular assist devices. Artif Organs 2014, 38(3):231-234.
28. Rees W., Schüler S., Hummel M., Hetzer R. Heart transplantation in patients with muscular dystrophy associated with end-stage cardiomyopathy. J Heart Lung Transplant 1993, 12:804-807.
29. Wu R.S., Gupta S., Brown R.N., et al. Clinical outcomes after cardiac transplantation in muscular dystrophy patients. J Heart Lung Transplant 2010, 29:432-438.
30. Banner N., Bonser R., Clark A., et al. UK guidelines for referral and assessment of adults for heart transplantation. Heart 2011, 97:1520-1527.